HBI
50
-11
ED
39
2
KMB
53
2
SE
80
-6
PEG
60
7
VRSK
73
-2
PBI
53
-3
EXPD
31
5
GWW
65
3
CINF
54
3
HIG
68
2
LB
44
-2
HAS
63
3
FE
59
3
MHK
45
2
GOOG
75
-2
ZION
63
4
T
63
-2
AES
31
5
CF
54
-2
HBI
50
-11
ED
39
2
KMB
53
2
SE
80
-6
PEG
60
7
VRSK
73
-2
PBI
53
-3
EXPD
31
5
GWW
65
3
CINF
54
3
HIG
68
2
LB
44
-2
HAS
63
3
FE
59
3
MHK
45
2
GOOG
75
-2
ZION
63
4
T
63
-2
AES
31
5
CF
54
-2
Financhill
Back

Keros Therapeutics Stock Predictions

10 Best Stocks to Own in 2025

Get your copy now FREE!
Sell
25

KROS
Keros Therapeutics

Last Price:
$14.07
Seasonality Move:
-5.28%

7 Day Trial

ALL ACCESS PASS

$ 7

10 stocks to buy for the next leg of this rally

Get the full list here FREE

Keros Therapeutics Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 4.1% based on the past 5 years of stock performance.
  • Keros Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Keros Therapeutics Stock Undervalued?
    The current Keros Therapeutics [KROS] share price is $14.02. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 4.1% based on the past 5 years of stock performance.

Keros Therapeutics Stock Rating

Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics overpriced?

  • Keros Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

  • The current trend is moderately bullish and KROS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
72.37
52-Week Low:
9.12

Prediction Charts

Market Cap:
569.4M
Price in USD:
14.02
Volume:
550.8K
Beta:
1.22

Technical Analysis

SMA50:
12.87
SMA100:
12.25
SMA200:
31.75
52-Wk Change:
-69.99%

Stock Predictions

  • Is Keros Therapeutics stock public?
    Yes, Keros Therapeutics is a publicly traded company.
  • What is the Keros Therapeutics stock quote today?
    The Keros Therapeutics stock price is 14.02 USD today.
  • How to buy Keros Therapeutics stock online?
    You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-9 13.89 13.65 14.22 13.57
May-12 13.78 13.74 14.24 13.44
May-13 13.59 13.47 13.71 13.21
May-14 13.57 13.59 13.75 13.14
May-15 13.66 14.03 14.04 13.39
May-16 14.08 14.07 14.22 13.76
May-19 14.05 14.10 14.44 13.95
May-20 14.10 14.14 14.25 13.91
May-21 14.07 14.04 14.28 13.72
May-22 13.90 14.16 14.24 13.89
May-23 14.01 14.57 14.74 14.01
May-27 14.63 14.35 14.69 14.17
May-28 14.45 14.64 14.91 14.37
May-29 14.41 14.02 14.54 13.81

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.00 per share, an increase this year of $4.40 per share, and a decrease next year of $4.42 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.